Ampio Provides Update on Clinical Trials for Ampion™ Treatment of COVID-19 Patients ...Middle East

ENGLEWOOD, Colo., Jan. 4, 2021 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today announced an update on the launch of a new global clinical...

Hence then, the article about ampio provides update on clinical trials for ampion treatment of covid 19 patients was published today ( Monday 04/01/2021 - 05:30 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Ampio Provides Update on Clinical Trials for Ampion™ Treatment of COVID-19 Patients )

Also on site :

• Another Weight Loss Surgery and a Wedding Bombshell: Spoilers From '1000-Lb Sisters' Season 8 Episode 2
• Trump-Iran latest: President threatens ‘very strong action’ if protesters are hanged after forced confessions
• Saks Global Secures $1.75 Billion of Committed Capital and Announces Return of Industry Veterans to Advance Transformation of Iconic Luxury Portfolio